|
PXL/HO/Cir-134/2025-26 Date: 07.02.2026
Hyderabad
Greetings from Pharmexcil,
Embassy of India in Seoul, South Korea in association with PHARMEXCIL is pleased to invite you to participate in the 16th edition of KOREA PHARM & BIO 2026 at the KINTEX-II during March 31~April 3, 2026. The details of the event are as follows:
KOREA PHARM & BIO 2026 (16th Edition)
March 31 – April 3, 2026
KINTEX-II, Goyang-si, Gyeonggi-do, South Korea
Supported by: Organized by Kyungyong Exhibition Corporation it is supported by Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), Ministry of Food and Drug Safety (MFDS), Korea Drug Research Association (KDRA), and Korea Pharmaceutical Traders Association (KPTA).
South Korea Pharmaceutical market is one of the largest and most advanced in Asia with total market size of US$ 28 Billion and the market is expected to grow annually between 7~9% till 2030. Historically a generics-focused manufacturing hub, the sector is rapidly transitioning into a global center for biopharmaceuticals, biosimilars, and innovative drug discovery, as Korea ranks #3 in New Drug Discovery. South Korea ranks #2 in FDA approved Biosimilars. The key growth drivers are ageing population and universal healthcare coverage.
Despite being a manufacturing powerhouse, Korea remains Import Dependent on APIs, Pharmaceutical Intermediates, Botanical Extracts, Chemicals etc. Korean Pharmaceutical market is a complexly Regulated, where foreign companies must have a local partner to help them in assisting regulatory approvals and they’re known as ICC (In-Country Caretaker).
Korea Pharm & Bio is a premier international exhibition focused on pharmaceuticals, biotechnology, APIs, chemicals, laboratory equipment, and packaging materials. It is the only exhibition officially supported by the Ministry of Food and Drug Safety (MFDS) and the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA).
The stall charges are as follows:
|
Sr. No
|
Sq. Meter Stand
|
Corner/ General
|
Rate
|
|
1
|
9 sq. meter stand
|
Corner
|
3.25 (Lakhs)
|
|
2
|
9 sq. meter stand
|
General
|
3.00 (Lakhs)
|
Note:
The above cost includes minimum furniture like 1 info counter, 1 meeting table, 2/3 chairs, 1 brochure stand, lights, fascia, 1 dust bin, electricity, badges and company name in the catalogue etc.
MSME/MAI Support to the Participants:
Members may kindly note that MSME/MAI assistance for this particular event is still awaited.
|
Invitation to Buyer Seller Meet & Round-Table Discussions:
The Embassy of India, Seoul and PHARMEXCIL are pleased to invite you to join the Indian Delegation and participate in this exhibition. We are pleased to announce the special program as mentioned below.
India–Korea Pharmaceutical & Bio Business Roundtable at
KOREA PHARM & BIO 2026.
Agenda: B2B Meeting, Company Presentation, MoU, Regulatory Guidance.
The Embassy of India in Seoul, in coordination with the event organizers, will organize two to three focused round-table meetings on APIs, formulations, biologics, and related areas on the sidelines of Korea Pharm & Bio 2026. In addition, B2B meetings between Indian exhibitors and Korean buyers—particularly mid-level procurement and sourcing professionals—are proposed.
Participation in both the round-table discussions and B2B meetings will be open exclusively to exhibitors.
To facilitate effective matchmaking, exhibitors are requested to submit a brief company profile, along with details of the products manufactured and/or exported. This information will be shared with prospective Korean counterparts in advance.
|
Allotment of Stalls:
With a view to make the allotment procedure easy and transparent, we made the reservation of stalls online:
Overall Layout
India Pavilion Layout
Online Reservation of Stalls
Stalls available in Korea Pharma within the " India Pavilion at Korea Pharma 2026" are as follows:
|
Sr. No.
|
Stall No.
|
IP No.
|
|
1
|
7C-308
|
IP-13
|
|
2
|
7C-306
|
IP-14
|
|
3
|
7C-304
|
IP-15
|
|
4
|
7D-307
|
IP-20
|
|
5
|
7D-305
|
IP-19
|
|
6
|
7D-308
|
IP-23
|
|
7
|
7D-304
|
IP-25
|
|
8
|
7D-206
|
IP-06
|
|
9
|
7E-207
|
IP-02
|
|
10
|
7E -205
|
IP-01
|
a)Membersmayreservestallsaspertheirpreference,subjecttoamaximumlimitoftwo(2)stallspermember. Incaseamemberreservesmorethantwostallsorstallsat differentlocations,theywillberequiredtoretain onlyonebookingof theirchoiceandreleasetheothers.
If noconfirmationemailisreceivedwithin15 minutesof booking,theCouncilreservestherighttoreleaseone stallwithoutpriornotice,inordertoallowothermembers toreservethestalls.
b)Stallpaymentmust bereleasedwithinfive(5)businessdaysfromthedateofreservation. Failuretodoso willresult intheautomatic cancellationofthereservation,andthestallwillbemadeavailableforreservation byothermembers.
CancellationofStalls:
Cancellationisnotallowedoncethestallisallotted. Reservationofstallgetsautomaticallycancelled,ifthe paymentis notreceivedwithinthescheduled time.
TojointheDelegationas Exhibitor,pleasecontactPHARMEXCILor3SMGContactPersonmentioned below. Rollins John,Directoratdirector.romumbai@pharmexcil.com(91-8920610648)
SusantaMahapatra,ManagingDirectoratmd@3smg.in (91-997198832)
Foranyfurtherclarifications,membersmayeithercontactMr.RollinsJohn,DirectorPharmexcilatPhone:+91
8920610648 and Phone: +91-22-31913512, or send an email toromumbai@pharmexcil.com with a copy
todirector.romumbai@pharmexcil.com.
Lookingforward toyourparticipation.
Thankingyou, Withregards,
RajaBhanu
Director General
NEFT/RTGS details
Name:Pharmaceuticals ExportPromotionCouncilof India
BankName:UnionBank ofIndia
A/c.No.510131000001693,A/c.type:CurrentAccountIFSC:UBIN0805220
Note:ForGST taxinvoicepleasecontactaccounts@pharmexcil.com
|
